JW
Janghee Woo
Winship Cancer Institute, Novartis Institutes for BioMedical Research Inc, University of Washington, Einstein Healthcare Network, Fred Hutchinson Cancer Center, Harvard University
0000-0001-9617-4301
Employment
-
Winship Cancer Institute2023 - Present
-
Novartis Institutes for BioMedical Research Inc Senior Clinical Program Lead2019 - 2023
-
Fred Hutchinson Cancer Center Associate Investigator2016 - 2019
-
University of Washington Instructor2016 - 2019
Education
-
University of Washington2014 - 2017
-
Einstein Healthcare Network2011 - 2014
-
Harvard University PhD2006 - 2011
-
Seoul National University College of Medicine MD2000 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (61)
- Supplementary Figure S1 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes Save
- Supplementary Table S4 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Supplementary Table S3 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Supplementary Table S1 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Supplementary Figure S2 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Supplementary Table S2 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Supplementary Figure S2 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save
- Network-Based Stratification Refines Stratification of Intermediate-Risk Acute Myeloid Leukemia Samples Save
- Supplementary Table S4 from Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial Save